Literature DB >> 34282728

Dynamically linking influenza virus infection kinetics, lung injury, inflammation, and disease severity.

Margaret A Myers1, Amanda P Smith2, Lindey C Lane2, David J Moquin3, Rosemary Aogo1, Stacie Woolard4, Paul Thomas4, Peter Vogel5, Amber M Smith1.   

Abstract

Influenza viruses cause a significant amount of morbidity and mortality. Understanding host immune control efficacy and how different factors influence lung injury and disease severity are critical. We established and validated dynamical connections between viral loads, infected cells, CD8+ T cells, lung injury, inflammation, and disease severity using an integrative mathematical model-experiment exchange. Our results showed that the dynamics of inflammation and virus-inflicted lung injury are distinct and nonlinearly related to disease severity, and that these two pathologic measurements can be independently predicted using the model-derived infected cell dynamics. Our findings further indicated that the relative CD8+ T cell dynamics paralleled the percent of the lung that had resolved with the rate of CD8+ T cell-mediated clearance rapidly accelerating by over 48,000 times in 2 days. This complimented our analyses showing a negative correlation between the efficacy of innate and adaptive immune-mediated infected cell clearance, and that infection duration was driven by CD8+ T cell magnitude rather than efficacy and could be significantly prolonged if the ratio of CD8+ T cells to infected cells was sufficiently low. These links between important pathogen kinetics and host pathology enhance our ability to forecast disease progression, potential complications, and therapeutic efficacy.
© 2021, Myers et al.

Entities:  

Keywords:  computational biology; immunology; inflammation; systems biology; viruses

Year:  2021        PMID: 34282728     DOI: 10.7554/eLife.68864

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  12 in total

1.  Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection.

Authors:  Romain Marlin; Mélanie Prague; Marie Alexandre; Severin Coleon; Nidhal Kahlaoui; Sylvain Cardinaud; Thibaut Naninck; Benoit Delache; Mathieu Surenaud; Mathilde Galhaut; Nathalie Dereuddre-Bosquet; Mariangela Cavarelli; Pauline Maisonnasse; Mireille Centlivre; Christine Lacabaratz; Aurelie Wiedemann; Sandra Zurawski; Gerard Zurawski; Olivier Schwartz; Rogier W Sanders; Roger Le Grand; Yves Levy; Rodolphe Thiébaut
Journal:  Elife       Date:  2022-07-08       Impact factor: 8.713

2.  Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy.

Authors:  Adrianne L Jenner; Munisha Smalley; David Goldman; William F Goins; Charles S Cobbs; Ralph B Puchalski; E Antonio Chiocca; Sean Lawler; Paul Macklin; Aaron Goldman; Morgan Craig
Journal:  iScience       Date:  2022-05-13

3.  Modeling explains prolonged SARS-CoV-2 nasal shedding relative to lung shedding in remdesivir-treated rhesus macaques.

Authors:  Ashish Goyal; Elizabeth R Duke; E Fabian Cardozo-Ojeda; Joshua T Schiffer
Journal:  iScience       Date:  2022-05-25

4.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

Review 5.  Protective and pathogenic role of humoral responses in COVID-19.

Authors:  Uni Park; Nam-Hyuk Cho
Journal:  J Microbiol       Date:  2022-03-02       Impact factor: 2.902

6.  Interferon-γ promotes monocyte-mediated lung injury during influenza infection.

Authors:  Taylor Schmit; Kai Guo; Jitendra Kumar Tripathi; Zhihan Wang; Brett McGregor; Mitch Klomp; Ganesh Ambigapathy; Ramkumar Mathur; Junguk Hur; Michael Pichichero; Jay Kolls; M Nadeem Khan
Journal:  Cell Rep       Date:  2022-03-01       Impact factor: 9.995

Review 7.  Mechanistic Models of COVID-19: Insights into Disease Progression, Vaccines, and Therapeutics.

Authors:  Rajat Desikan; Pranesh Padmanabhan; Andrzej M Kierzek; Piet H van der Graaf
Journal:  Int J Antimicrob Agents       Date:  2022-05-16       Impact factor: 15.441

8.  Human placental hematopoietic stem cell derived natural killer cells (CYNK-001) mediate protection against influenza a viral infection.

Authors:  Joseph Gleason; Yuechao Zhao; Irene Raitman; Lin Kang; Shuyang He; Robert Hariri
Journal:  Hum Vaccin Immunother       Date:  2022-04-11       Impact factor: 4.526

9.  Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model.

Authors:  Judy D Day; Soojin Park; Benjamin L Ranard; Harinder Singh; Carson C Chow; Yoram Vodovotz
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

10.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infection during SARS-CoV-2 Infection.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  bioRxiv       Date:  2022-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.